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ABSTRACT
Temporal data on gene expression and context-
specific open chromatin states can improve identi-
fication of key transcription factors (TFs) and the
gene regulatory networks (GRNs) controlling cel-
lular differentiation. However, their integration re-
mains challenging. Here, we delineate a general ap-
proach for data-driven and unbiased identification
of key TFs and dynamic GRNs, called EPIC-DREM.
We generated time-series transcriptomic and epige-
nomic profiles during differentiation of mouse multi-
potent bone marrow stromal cell line (ST2) toward
adipocytes and osteoblasts. Using our novel ap-
proach we constructed time-resolved GRNs for both
lineages and identifed the shared TFs involved in
both differentiation processes. To take an alternative
approach to prioritize the identified shared regula-
tors, we mapped dynamic super-enhancers in both
lineages and associated them to target genes with
correlated expression profiles. The combination of
the two approaches identified aryl hydrocarbon re-
ceptor (AHR) and Glis family zinc finger 1 (GLIS1)
as mesenchymal key TFs controlled by dynamic
cell type-specific super-enhancers that become re-
pressed in both lineages. AHR and GLIS1 control
differentiation-induced genes and their overexpres-
sion can inhibit the lineage commitment of the mul-
tipotent bone marrow-derived ST2 cells.
INTRODUCTION
Understanding the gene regulatory interactions underly-
ing cell differentiation and identity has become increas-
ingly important, especially in regenerative medicine. Effi-
cient and specific reprogramming of cells toward desired
differentiated cell types relies on understanding of the
cell type-specific regulators and their targets (1). Similarly,
knowledge of the regulatory wiring in the intermediate
stages might allow controlled partial dedifferentiation, and
thereby endogenous regeneration, also in mammals (2).
Great progress has beenmade in reconstruction ofGRNs
for various cell types in recent years.While successful, many
of the approaches derive their regulatory interactions from
existing literature and databases, which may be limiting as
the majority of enhancers harboring transcription factor
(TF) binding sites are cell type-specific (3). Thus, the regu-
latory interactions derived from existing databases and lit-
erature might be misleading and are likely to miss impor-
tant interactions that have not been observed in other cell
types. Therefore, context-specific expression data have been
used to overcome such biases and allow a data-driven net-
work reconstruction (4). In addition, other approaches tak-
ing advantage of time-series data, such as Dynamic Reg-
ulatory Events Miner (DREM) (5), have been developed
to allow hierarchical identification of the regulatory inter-
actions. However, while time-series epigenomic data has
been used in different studies to derive time point-specific
GRNs (6,7), systematic approaches that integrate the dif-
ferent types of data in an intuitive and automated way are
missing.
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The central key genes of biological networks under multi-
way regulation by many TFs and signaling pathways were
recently shown to be enriched for disease genes and are
often controlled through so called super-enhancers (SEs),
large regulatory regions characterized by broad signals for
enhancermarks likeH3 lysine 27 acetylation (H3K27ac) (8–
11). Hundreds of SEs can be identified per cell type, many of
which are cell type- or lineage-specific and usually control
genes that are important for the identity of the given cell
type or condition. Thus, SE mapping and SE target iden-
tification can facilitate unbiased identification of novel key
genes.
An example of lineage specification events with biomedi-
cal relevance is the differentiation of multipotent bone mar-
row stromal progenitor cells toward two mesenchymal cell
types: osteoblasts and bone marrow adipocytes. Due to
their shared progenitor cells, there is a reciprocal balance
in the relationship between osteoblasts and bone marrow
adipocytes. Proper osteoblast differentiation and matura-
tion toward osteocytes is important in bone fracture heal-
ing and osteoporosis and osteoblast secreted hormones like
osteocalcin can influence insulin resistance (12,13). At the
same time bone marrow adipocytes, that occupy as much
as 70% of the human bone marrow (14), are a major source
of hormones promoting metabolic health, including insulin
sensitivity (15). Moreover, increased commitment of the
progenitors toward the adipogenic lineage upon obesity and
aging was recently shown to inhibit both bone healing and
the hematopoietic niche (16).
Extensive temporal epigenomic analysis of osteoblasto-
genesis has been recently reported (17). Moreover, a par-
allel investigation of adipocytes and osteoblasts differenti-
ated from the same primary bone marrow-derived progen-
itor cells was performed by Meyer et al. (18). Such analy-
sis can help to understand both the lineage-specific and the
shared regulators important for their (de)differentiation.
To further identify shared regulators of adipocyte and os-
teoblast commitment, and to delineate a general approach
for systematic unbiased identification of key regulators, we
performed time-series epigenomic and transcriptomic pro-
filing at six different time points over 15-day differentia-
tion of multipotent bone marrow stromal cell line (ST2
cells) toward both adipocytes and osteoblasts. We com-
bine segmentation-based TF binding predictions from time
point-specific active enhancer data (19) with probabilistic
modeling of temporal gene expression data (5) to derive dy-
namicGRNs for both lineages. Bymerging overlapping SEs
identified using H3K27ac signal from different time points
we obtained dynamic profiles of SE activity across the two
differentiations and use these dynamic SEs to prioritize the
key regulators identified through the network reconstruc-
tion.With this approach, we identified aryl hydrocarbon re-
ceptor (AHR) and Glis family zinc finger 1 (GLIS1) as cen-
tral regulators of multipotent mesenchymal cells under dy-
namic control from SEs that become repressed in the differ-
entiated cells. Overexpression of either of the TFs is able to
inhibit adipogenesis and GLIS1 can also prevent osteoblast
differentiation. The repression of these TFs, and in partic-
ular of AHR, allows upregulation of many adipocyte- and
osteoblast-specific genes, includingNotch genes, a family of
conserved developmental regulators.
MATERIALS AND METHODS
Cell culture
The mouse multipotent bone marrow stromal ST2 cell line,
established fromWhitlock-Witte type long-term bone mar-
row culture of BC8 mice (20), was used during all exper-
iments. The hypotetraploid cells were grown in Roswell
Park Memorial Institute (RPMI) 1640 medium (Gibco,
Life Technologies, 32404014) supplemented with 10% fe-
tal bovine serum (FBS) (Gibco, Life Technologies, 10270–
106, lot #41F8430K) and 1% L-Glutamine (Lonza, BE17–
605E) in a constant atmosphere of 37◦C and 5% CO2. All
experiments were carried out with cells passaged for less
than 10 times. For differentiation into adipocytes and os-
teoblasts, ST2 cells were seeded 4 days before differenti-
ation (day-4), reached 100% confluency after 48 h (day-
2) and were further maintained for 48 h post-confluency
(day 0). Adipogenic differentiation was subsequently ini-
tiated on day 0 (D0) by adding differentiation medium I
consisting of growth medium, 0.5 mM isobutylmethylxan-
thine (IBMX) (Sigma-Aldrich, I5879), 0.25 M dexam-
ethasone (DEXA) (Sigma-Aldrich, D4902) and 5 g/ml
insulin (Sigma-Aldrich, I9278). From day 2 (D2) on dif-
ferentiation medium II consisting of growth medium, 500
nM rosiglitazone (RGZ) (Sigma-Aldrich, R2408) and 5
g/ml insulin (Sigma-Aldrich, I9278) was added and re-
placed every 2 days until 15 days of differentiation. Os-
teoblastic differentiation was induced with growth medium
supplementedwith 100 ng/ml bonemorphogenetic protein-
4 (BMP-4) (PeproTech, 315–27). Same media was replaced
every 2 days until 15 days of osteoblastogenesis. The dif-
ferentiation efficiency was controlled by real-time quantita-
tive polymerase chain reaction (RT-qPCR) of established
marker genes and by observing cell morphology and Oil
Red O or von Kossa stainings (Supplementary Figure S1).
Generation of stable cell lines
To generate stable ST2 cell lines with integration of
CopGFP gene, Ahr gene or Glis1 gene under a Tet-On 3G
promoter (ST2-TetOn-GFP, ST2-TetOn-AHR, and ST2-
TetOn-GLIS1, respectively) for inducible overexpression
of the indicated genes, ST2 cell were transduced with
lentiviral particles from Sirion Biotech (Germany) at a
MOI of 2.0 together with reverse tetracycline transactiva-
tor (rtTA) under the control of the mouse cytomegalovirus
promoter (mCMV). Transduced ST2 cells were then se-
lected by adding puromycin (InvivoGen, ant-pr-1) to the
growth medium at a concentration of 1 g/ml. Induction
of CopGFP, Ahr or Glis1 was achieved by adding doxycy-
cline (Takara, 631311) at a concentration of 1 g/ml (stock
concentration 1 mg/ml in sterile filtered distilled water).
Gene silencing
Undifferentiated ST2 cells (day-1) were transfected with
Lipofectamine RNAiMAX (Life Technologies, 13778150)
according to manufacturer’s instructions using 50 nM of
gene-specific siRNAs against mouse Ahr (siAhr) (Dharma-
con, M-044066–01-0005), Glis1 (siGlis1) (Dharmacon, M-
065576–01-0005) or 50 nM of a negative control siRNA
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duplexes (siControl) (Dharmacon, D-001206–14-05). Cells
were collected 48 h post-transfection. Sequences of the siR-
NAs are listed in Supplementary Table S1.
Western blotting
After washing the cells with 1× phosphate-buffered saline
(PBS), and addition of 1× La¨emmli buffer, the lysates
were vortexed and the supernatants were heated at 95◦C
for 7 min. Proteins were subjected to sodium dodecyl
sulphate-polyacrylamide gel electrophoresis (SDS-PAGE)
(10% gel) and probed with the respective antibodies. The
following antibodies were used: anti-AHR (Enzo Life Bio-
sciences, BML-SA210–0025), anti-ACTIN (Merck Milli-
pore, MAB1501). HRP-conjugated secondary antibodies
were purchased from Cell Signaling. Signals were detected
on a Fusion FX (Vilber Lourmat) imaging platform, us-
ing an ECL solution containing 2.5 mM luminol, 100 mM
Tris/HCl pH 8.8, 0.2 mM para-coumaric acid, and 2.6 mM
hydrogenperoxide.
RNA extraction and cDNA synthesis
Total RNAwas extracted from ST2 cells using TRIsure (Bi-
oline, BIO-38033). Medium was aspirated and 1000 l of
TRIsure was added to 6-wells. To separate RNA fromDNA
and proteins, 200 l of chloroform (Carl Roth, 6340.1) was
added. To precipitate RNA from the aqueous phase, 400
l of 100% isopropanol (Carl Roth, 6752.4) was added and
RNA was incubated at −20◦C overnight. cDNA synthesis
was done using 1 g of total RNA, 0.5 mM dNTPs (Ther-
moFisher Scientific, R0181), 2.5 M oligo dT-primer (Eu-
rofins MWG GmbH, Germany), 1 U/l Ribolock RNase
inhibitor (ThermoFisher Scientific, EO0381) and 1 U/l
M-MulV Reverse transcriptase (ThermoFisher Scientific,
EP0352) for 1 h at 37◦C or 5 U/ l RevertAid Reverse tran-
scriptase for 1 h at 42◦C. The PCR reaction was stopped by
incubating samples at 70◦C for 10 min.
Quantitative PCR
RT-qPCR was performed in an Applied Biosystems 7500
Fast Real-Time PCR System and using Thermo Scien-
tific Absolute Blue qPCR SYBR Green Low ROX Mix
(ThermoFisher Scientific, AB4322B). In each reaction 5
l of cDNA, 5 l of primer pairs (2 M) and 10 l of
the Absolute Blue qPCR mix were used. The PCR reac-
tions were carried out at the following conditions: 95◦C
for 15 min followed by 40 cycles of 95◦C for 15 s, 55◦C
for 15 s and 72◦C for 30 s. To calculate the gene expres-
sion level the 2−(Ct) method were used where Ct
is equal to (Ct(target gene) – Ct(housekeeping gene))tested condition
- (Ct(target gene) – Ct(housekeeping gene))control condition. Rpl13a
was used as a stable housekeeping gene and D0, siControl,
or untreated cells were used as control conditions. Se-
quences of the primer pairs are listed in Supplementary Ta-
ble S1.
Chromatin immunoprecipitation
Chromatin immunoprecipitation of histone modifications
was performed on indicated time points of adipocyte and
osteoblast differentiation. Cells were grown on 10 cm2
dishes. First, chromatin was cross-linked with formalde-
hyde (Sigma-Aldrich, F8775–25ML) at a final concentra-
tion of 1% in the culture media for 8 min at room tem-
perature. Then, the cross-linked reaction was quenched
with glycine (Carl Roth, 3908.3) at a final concentra-
tion of 125 mM for 5 min at room temperature. The
formaldehyde-glycine solution was removed and cells were
washed twice with ice-cold PBS (Lonza, BE17–516F) con-
taining cOmplete™ mini Protease Inhibitor (PI) Cocktail
(Roche, 11846145001). Then, cells were lysed in 1.7 ml of
ice-cold lysis buffer [5 mM 1,4-Piperazinediethanesulfonic
acid (PIPES) pH 8.0 (Carl Roth, 9156.3); 85 mM potas-
sium chloride (KCl) (PanReac AppliChem, A2939); 0.5%
4-Nonylphenyl-polyethylene glycol (NP-40) (Fluka Bio-
chemika, 74385)] containing PI and incubated for 30 min
on ice. The cell lysates were then centrifuged at 660 × g
for 10 min at 7◦C and the pellet was resuspended in 400 l
of ice-cold shearing buffer [50 mM Tris Base pH 8.1 (Carl
Roth, 4855.2); 10 mM ethylenediamine tetraacetic acid
(EDTA) (Carl Roth, CN06.3); 0.1% SDS (PanReac Ap-
plichem, A7249); 0.5% Sodium deoxycholate (Fluka Bio-
chemika, 30970)] containing PI. Chromatin was sheared
with a sonicator (Bioruptor®Standard Diagenode, UCD-
200TM-EX) during 20 cycles at high intensity (30 s off and
30 s on) for the ST2 cells differentiated into adipocytes and
osteoblasts and 25 cycles at high intensity (30 s off and
30 s on) for the ST2 differentiated into osteoblasts for 9
days on. The sheared cell lysate was then centrifuged at
20817 × g for 10 min at 7◦C and the supernatant con-
taining the sheared chromatin was transferred to a new
tube. For each immunoprecipitation 10 g (for H3K4me3)
or 15 g (for H3K27ac and H3K36me3) of sheared chro-
matin and 4 g as input were used. The sheared chro-
matin was diluted 1:10 with modified RIPA buffer [140 mM
NaCl (Carl Roth, 3957.2); 10 mM Tris pH 7.5 (Carl Roth,
4855.2); 1 mM EDTA (Carl Roth, CN06.3); 0.5 mM ethy-
lene glycol-bis(-amino-ethyl ether)-N,N,N’,N’-tetraacetic
acid (EGTA) (Carl Roth, 3054.3); 1% Triton X-100 (Carl
Roth, 3051.2); 0.01% SDS (PanReac Applichem, A7249);
0.1% sodium deoxycholate (Fluka Biochemika, 30970)]
containing PI. The diluted sheared chromatin was incu-
bated overnight with the recommended amount provided
by themanufacturer of an antibody againstH3K4me3 (Mil-
lipore, 17–614), 5 g of an antibody against H3K27ac (Ab-
cam, ab4729) or 5 g of an antibody against H3K36me3
(Abcam, ab9050). The next day, the antibodies were cap-
tured using 25 l of PureProteome™ Protein A Magnetic
(PAM) Bead System (Millipore, LSKMAGA10) for 2 h at
4◦C on a rotating wheel. After, the PAM beads were cap-
tured using a DynaMag™-2 magnetic stand (Life Technolo-
gies, 12321D). The supernatant was discarded and the PAM
beads were washed twice with 800 l of Immunoprecipi-
tation wash buffer 1 (IPWB1) [20 mM Tris, pH 8.1 (Carl
Roth, 4855.2); 50 mM NaCl (Carl Roth, 3957.2); 2 mM
EDTA (Carl Roth, CN06.3); 1% Triton X-100 (Carl Roth,
3051.2); 0.1% SDS (PanReac Applichem, A7249)], once
with 800l of Immunoprecipitation wash buffer 2 (IPWB2)
[10 mM Tris, pH 8.1 (Carl Roth, 4855.2); 150 mM NaCl
(Carl Roth, 3957.2); 1 mM EDTA (Carl Roth, CN06.3),
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1% NP-40 (Fluka Biochemika, 74385), 1% sodium deoxy-
cholate (Fluka Biochemika, 30970), 250 mM of lithium
chloride (LiCl) (Carl Roth, 3739.1)] and twice with 800 l
of Tris-EDTA (TE) buffer [10 mM Tris, pH 8.1 (Carl Roth,
4855.2); 1 mM EDTA (Carl Roth, CN06.3), pH 8.0]. At
last, the PAM beads and the inputs were incubated with
100 l of ChIP elution buffer [0.1 M sodium bicarbonate
(NaHCO3) (Sigma-Aldrich, S5761); 1% SDS (PanReac Ap-
plichem, A7249)]. The cross-linking was reversed by adding
10 g of RNase A (ThermoFisher, EN0531) and 20 g of
proteinase K (ThermoFisher, EO0491) at 65◦C overnight.
Then, the eluted chromatin was purified using a MinE-
lute Reaction CleanupKit (Qiagen, 28206) according to the
manufacturer’s instructions. The DNA concentration was
measured using the Qubit® dsDNA HS Assay Kit (Ther-
moFisher, Q32851) and the Qubit 1.0 fluorometer (Invitro-
gen, Q32857) according to the manufacturer’s instructions.
The ChIP assays were performed at each time point in
three biological replicates, one of which was subjected to
high-throughput sequencing. The enrichment profiles at
four selected loci were validated on all three biological repli-
cates by ChIP-PCR (data not shown).
ChIP-Seq
The sequencing of the ChIP samples was done at the
Genomics Core Facility in EMBL Heidelberg, Germany.
For sequencing, single-end and unstranded reads were
used and the samples were processed in an Illumina CBot
and sequenced in an Illumina HiSeq 2000 machine. In
total, 979 572 918 raw reads were obtained. Raw reads
quality was assessed by fastqc [v0.11, (21)]. This quality
control unveiled that some reads were containing part of
the adapters. Those spurious sequences were cleaned up
from the genuine mouse sequences by AdapterRemoval
(22) [v1.5]. The PALEOMIX pipeline (23) [v1.0.1] was
used for all steps from FASTQ files to BAM files including
trimming, mapping, and duplicate marking. This workflow
ensures that all files are complete and valid. Retained reads
were required to have a minimum length of 25 bp. Bases
with unreliable Phred scores (0–2) were trimmed out. In
total 31 909 435 reads were discarded (3.26%). Eventually,
947 663 483 reads were retained (96.74%). Trimmed reads
were further mapped using BWA (24) [v0.7.10] with the
backtrack algorithm dedicated to short sequences. The
mouse reference was the mouse genome GRCm38.p3
(mm10, patch 3) downloaded from NCBI. For validating,
merging BAM files, and marking duplicates, we used the
suite tool Picard [v1.119, (25)]. Duplicates were marked
but not removed. Only reads with a mapping quality
of 30 were retained to ensure a unique location on the
genome resulting in 661 364 143 reads (69.79% of the
trimmed reads). The samples with a coverage of less than 8
million reads (mapping quality > 30) were excluded from
the downstream analysis. Raw FASTQ and BAM files
have been deposited in the European Nucleotide Archive
with the accession number PRJEB20933. The ChIP-
seq tracks are available at the UCSC Genome Browser
(http://genome.ucsc.edu/cgi-bin/hgTracks?hubUrl=https:
//biostat2.uni.lu/dgerard/hub.txt&genome=mm10).
The ChIP-Seq peaks were called with Model-based anal-
ysis of ChIP-Seq (26) (MACS) version 2.1.0 for H3K4me3,
with HOMER (27) for H3K27ac, and with SICER (28) ver-
sion 1.1 for H3K36me3, using input from undifferentiated
ST2 cells as control for IPs from D0 cells and input from
D5 adipocyte- or osteoblast-differentiated cells for the IPs
from the respectively differentiated cells.
RNA-Seq
The sequencing of the time course samples (Figure 1) was
done at the Genomics Core Facility in EMBL Heidelberg,
Germany. For sequencing, single-end and unstranded reads
were used and the samples were processed in an Illumina
CBot and sequenced in an Illumina NextSeq machine.
The sequencing of the AHR knock-down samples
was performed at the Luxembourg Center for Systems
Biomedicine (LCSB) Sequencing Facility. The TruSeq
Stranded mRNA Library Prep kit (Illumina) was used to
prepare the library for sequencing with 1 g of RNA as
startingmaterial according tomanufacturer’s protocol. The
library quality was checked using an Agilent 2100 Bioana-
lyzer and quantified using Qubit dsDNAHS assay Kit. The
libraries were then adjusted to 4 nM and sequenced on a
NextSeq 500 (Illumina) according to the manufacturer’s in-
structions.
The obtained reads were quality checked using FastQC
version 0.11.3 (21). Cutadapt version 1.8.1 (29) was used
to trim low quality reads (-q 30 parameter), remove Illu-
mina adapters (-a parameter), remove reads shorter than
20 bases (-m 20 parameter) with an error tolerance of 10%
(-e 0.1 parameter). Then, removal of reads mapping to
rRNA species was performed using SortMeRNA (30) with
the parameters --other, --log, -a, -v, --fastx en-
abled. Lastly, the reads were quality checked using FastQC
version 0.11.3 to control whether bias could have been in-
troduced after the removal of Illumina adapters, low qual-
ity reads and rRNA reads. Then, the reads were mapped
to the mouse genome mm10 (GRCm38.p3) and using the
gene annotation downloaded from Ensembl (release 79) us-
ing the Spliced Transcripts Alignment to a Reference (31)
(STAR) version 2.5.2b using the previously described pa-
rameters (32). The reads were counted using the function
featureCounts from the R package Rsubread (33) version
1.4.6-p3 and the statistical analysis was performed using
DESeq2 (34) version 1.14.1 in R 3.3.2 and RStudio (RStu-
dio Team (2015). RStudio: Integrated Development for R.
RStudio, Inc., Boston, MA, USA).
EPIC-DREM analysis
To identify TFs that have a regulatory function over time,
we designed a new computational workflow that combines
the computational TF prediction method TEPIC (19) with
DREM (5), a tool to analyze the dynamics of transcrip-
tional regulation.
We identified TF footprints in the H3K27ac signal us-
ing HINT-BC (35), which is included in the Regulatory Ge-
nomics Toolbox, version 0.9.9. Next, we predicted TF bind-
ing in those footprints using TEPIC, version 2.0 (36).We
used the provided set of 687 PWMs for Mus musculus and
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Figure 1. Time-series RNA-seq andChIP-seq profiling of adipocyte and osteoblast differentiation from shared bonemarrow progenitor cells. (A) Schematic
representation of the experimental set-up. ST2 cells were differentiated toward adipocytes or osteoblasts. Total RNA and chromatin was collected at the
indicated time points from both differentiation time courses and subjected to RNA-seq or ChIP-seq analysis using antibodies against the indicated histone
modifications. (B) Principle component analysis of the RNA-seq data. All replicates are indicated with each time point in a different color. Triangles marks
the undifferentiated ST2 cells, circles the adipocyte (Ad) samples and squares the osteoblast (Ob) samples. (C) Venn diagram comparing all differentially
expressed genes at any time point of adipogenesis (log2FC > 1, FDR < 0.05) to those similarly affected in osteoblastogenesis. (D) Heatmap depicting the
top 100 genes with the highest variance across the time points and lineages.
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mouse genome version mm10 (GRCm38) to predict TF
affinities using TRAP (37) within TEPIC. As DREM re-
quires a time point-specific prediction of binding of a reg-
ulator with its target, we needed to develop an approach
to determine a suitable TF-specific affinity cut-off, for each
time point. For this, we created a similar set of random re-
gions thatmirrors theGC content and length distribution of
the original sequences of the footprints. TF affinities ar cal-
culated in the random regions are used to determine a suit-
able cut-off for the original affinities ao using the frequency
distribution of the TF affinities. Affinities for TFi are de-
noted by ari and aoi . Let r ∈ R denote a randomly chosen
genomic region that is screened for TF binding, and let |r |
denote its length. Analogously, let o ∈ O denote a footprint
that is screened for TF binding, and let |o| denote its length.
We normalize both ari and aoi by the length of their corre-
sponding region and obtain the normalized TF affinities a′ri
and a′oi :
a′ri =
ari
|r | , a
′
oi =
aoi
|r | .
Using the distribution of a′ri values we derive a TF-
specific affinity threshold ti for a P-value cut-off of 0.05
(See section ChIP-seq validation of TEPIC affinity cut-off
for how this P-value was chosen). For a TFi , we compute
a binary affinity value boi from the original affinity a
′
oi ac-
cording to the cut-off ti with:
boi =
{
1, a′oi > ti
0, a′oi ≤ ti
The binary affinity valuesboi can be used to compute a
binary TF–gene association agi between gene g and TF i:
agi =
{
1, ∃o ∈ Ogw : a′oi = 1
0, otherwi se , where Ogw denotes all
footprint regions that occur within a window of size w
around the TSS of gene g.
Informally, a gene g is associated to TFi if there is a pre-
dicted binding site within a window of predefined size w
around the gene’s TSS. Here, we use w = 50kb.
Together with gene expression estimates, the TF–gene
associations can be directly used as input to DREM. In
this analysis, we used version 2.0.3 of DREM. The entire
workflow of EPIC-DREM is shown in Figure 2A. TEPIC
is available online at https://github.com/SchulzLab/TEPIC,
DREM can be downloaded at http://www.sb.cs.cmu.edu/
drem/.
ChIP-seq validation of TEPIC affinity cut-off
To validate that the affinity threshold described above in-
deed results in an adequate separation between bound and
unbound sites, we conducted a comparison to TF-ChIP-seq
data. We obtained TF-ChIP-seq data from ENCODE for
K562 (18 TFs), HepG2 (36 TFs) and GM12878 (24 TFs).
In addition, we downloaded H3K27ac data for the men-
tioned cell lines from ENCODE. A list of all ENCODE
accession numbers is provided in Supplementary Table S2.
As described above, we called footprints using HINT-BC
and calculated TF affinities in the footprints as well as in
the randomly selected regions that map the characteristics
of the footprints. To understand the influence of different
thresholds, we calculated affinity thresholds for the follow-
ing P-values: 0.01, 0.025, 0.05, 0.075, 0.1, 0.2, 0.3, 0.4 and
0.5. All affinities below the selected affinity value are set to
zero, the remaining values are set to one. The quality of the
discretization is assessed through the following ‘peak cen-
tric’ validation scheme, as used before in (38). The positive
set of the gold standard is comprised of all ChIP-seq peaks
that contain a motif predicted by FIMO (39), the negative
set contains all remaining ChIP-seq peaks. A prediction is
counting as a true positive (TP) if it overlaps the positive set,
it counts as a false positive (FP) it if overlaps the negative
set. The number of false negatives (FN) is the number of
all entries in the positive set that are not overlapped by any
prediction. For all TFs in all cell lines we calculate Precision
(PR) and Recall (REC) according to
PR = TP
TP + FP , REC =
TP
TP + FN .
As one can see, Precision is increasing with a stricter P-
value threshold, while Recall is decreasing. We found that
using 0.05 seems to be a reasonable compromise between
Precision and Recall. The median Precision and Recall val-
ues calculated over all cell lines and all TFs are shown in
Supplementary Figure S2A. Detailed results on a selection
of TFs that are present in all three cell lines are shown in
Supplementary Figure S2B.
Generating TF–TF interaction networks for DREM splits
We devised a general strategy to create TF–TF interaction
networks for individual DREM splits. For a split of interest,
we retrieve the top 25 regulators T, ranked according to the
DREM split score. For each regulator t ∈ T, we determine
the target genes Gt by declaring each gene g to be a target of
TFt, if and only if ag,t = 1, where ag,t is the binary value for
the TF affinity of TFtin the vicinity of gene g, as introduced
above. Here, we want to show only interactions among the
top regulators, thus, in order to include a directed edge from
t to g in the TF–TF network, it must hold that g ∈ T. For
reasons of simplicity, we limit the number of shown interac-
tions per TFt to 10, ranked by the numerical affinity values
across all g ∈ Gt.
Additionally, we scale the size of each node representing a
regulator t ∈ T, according to its total number of target genes
|Gt | |in six discrete levels (<2000, <4000, <6000, <8000,
<10 000 and >10 000). This allows an interpretation of the
importance of the regulator outside the scope of the inter-
actions among the top TFs for the shown split. The node
color indicates the expression change of the depicted TF
compared to time-point zero. Orange refers to downregu-
lation, whereas blue refers to upregulation.
The networks are arranged with graphviz and the neato
layout algorithm (40).
DREM-TRAP and random TF–gene assignment
To assess the impact of epigenetics data on DREM pre-
dictions, we designed a baseline approach, assuming that
most transcriptional regulation for a gene is occurring in
its promoter region. Hence, for each gene g, we consider
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1240/5245443 by Lasse Sinkkonen on 14 D
ecem
ber 2018
Nucleic Acids Research, 2018 7
A
C
(i)
(iv)(v)
(ii) (iii)
Epigenetic signals Footprint / Peak Calling Computing TF gene scores
50kb
TSS Gene 1
TF1
TF2
time 1 time 2
TF1 TF2 TF3
Gene 1 0 0 0
Gene 2 1 0 0
Gene 3 0 0 1
… … … …
TF1 TF2 TF3
Gene 1 0 1
Gene 2 1 0 0
Gene 3 0 0 1
… … …
TF1 TF2 TF3
Gene 1 0 1 1
Gene 2 1 0 0
Gene 3 0 0 1
… … … …
Gene 1 95
Gene 2 1.2
Gene 3 1.4
Gene 1 …
Gene 1 43
Gene 2 1.2
Gene 3 1.4
Gene 1 …
Gen  1 0.9
Gen  2 23
Gene 3 18
… …
TF gene scores per gene 
and timepoint
DREM predicted regulators at split nodesGene expression 
data
B
F
ra
ct
io
n
 o
f 
th
e 
p
re
d
ic
te
d
 T
F
s 
kn
o
w
n
 t
o
 r
eg
u
la
te
 in
d
ic
at
ed
 li
n
ea
g
e
G
en
e 
E
xp
re
ss
io
n
1.0
0.8
0.6
0.4
0.2
0.0
DREM 2.0 DREM-TRAP EPIC-DREM Random
Setup
Adipocyte
Osteoblast
20
22
21
15
35
26
13
8
150
100
50
0
D
R
E
M
 S
p
lit
 s
co
re
Cell type
Adipo Osteo
EPIC-DREM
DREM-TRAP
DREM 2.0
Random
Figure 2. Workflow of the EPIC-DREM approach and benchmarking against other methods. (A) (i–iii) From time-series epigenetic experiments, e.g.
DNase1-seq or histone ChIP-seq, putative TF binding sites are identified through footprint/peak calling and are annotated with TF affinities using TRAP.
Random genomic regions with similar genomic characteristics (GC-content and length) compared to measured footprints/peaks are generated and anno-
tated with TF affinities as well. A TF- and timepoint-specific affinity threshold can be obtained by applying an empirical P-value threshold (e.g. 0.05) on
the distribution of TF affinities calculated on the randomly selected regions. Applying the threshold on the TF affinities computed in (iii) results in a set of
discrete TF affinities per TF and timepoint. (iv) Using TEPIC, the discrete TF affinities are integrated into discrete, timepoint-specific TF–gene association
scores. (v) The discrete, time-point specific TF–gene association scores together with the time-series gene-expression data are used within DREM to predict
regulators that distinguish subsets of genes showing similar gene expression changes over time. Here, at the beginning of the time course, DREM identifies
two sets of genes, denoted by the red and yellow lines, denoting two distinct expression patterns that are associated to TF1 and TF2. Going on to the
next time point, DREM suggests that the red and yellow gene sets form two subgroups each, black and blue, as well as brown and purple, respectively.
TF binding predictions for EPIC-DREM have been included in the TEPIC 2.0 software (36) (B) Benchmarking of the different methods. The time-series
data from ST2 cell differentation to adipocytes and osteoblasts (Figure 1A) was used as input for four different approaches (DREM2.0, EPIC-DREM,
DREM-TRAP and random TF–target assignment) to identify TFs controlling the respective lineages. Per time point, we consider the top 15 TFs ranked
according to their DREM score. For each identified TF the literature was searched for existing evidence for that TFs role in maintaining mesenchymal
stem cells or for its involvement in differentiation to either adipocytes or osteoblasts. Supplementary Table S4 provides the retrieved literature references.
The fraction of the predicted TFs for which we found supporting literature is shown per method and lineage, with the total number of identified unique
top TFs indicated. (C) The distributions of the obtained DREM split scores per method and lineage are shown, with EPIC-DREM typically obtaining
highest scores at most split points.
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a 2 kb window around the most 5′ TSS of g. Within this
window, we compute TF affinities as described above for
687 PWMs for M. musculus and mouse genome version
mm10 (GRCm38). Also, we applied the same thresholding
approach as described for EPIC-DREM. Thereby, DREM-
TRAP represents approaches that are purely sequence and
annotation based and do not account for changes in the
chromatin.
As another sanity check for EPIC-DREM, we permuted
the EPIC-DREM input matrix, which is based on time-
point specific footprint calls. In detail, we randomly shuf-
fled column 1 (TF), column 2 (target gene) and column
4 (time point). Thus the number of TFs, target genes and
timepoint entries is not affected, only the mapping between
them changed.
Enrichment score of DREM splits, its aggregation and liter-
ature evaluation of suggested regulators
DREM uses a hypergeometric distribution to assess the as-
sociation of a TF to genes in a distinct path, the so called
split-score, where a lower value means a stronger associa-
tion. Because we carry out a considerable number of tests
per split (as we test more than 600 TFs), we correct the split-
scores for multiple testing using Bonferroni correction.
To compare the enrichment scores across the different
versions of DREM used in this manuscript, we –log2 trans-
formed the Bonferroni corrected split-scores and show vi-
olin plots of the transformed scores, which we call DREM
split score. For those scores, the higher the value, the bet-
ter is the association of the TFs identified at split points to
genes on the adjacent paths.
To identify essential TFs across multiple splits at one
time point, we perform P-value aggregation using Fisher’s
method on the split scores, i.e. we compute
Xt.n = −2
s∑
i = 1
log (pn,i,t)
Here, Xt,n is the aggregated score for TFt at time point
n, i is the current split, s indicates the number of splits at
Timepoint n and pn,i,t is the split score for TFt at split i at
time point n. Next, we rank the, Xt,n by time point n and
thereby obtain a list of top regulators per time point.
We obtained such lists for DREM2.0, EPIC-DREM,
DREM-TRAP and the random TF–gene assignment de-
lineated in the previous section. For each time point and
method, we consider the top 15 TFs and screened literature
to learn about whether these TFs are known to play a role
in mesenchmymal stem cells or in differentiation of either
adipocytes or osteoblasts. Note that in case a TF is selected
inmultiple time points, it counts only once. To directly com-
pare the quality of the predictions between the DREM ver-
sions, we compute the precision of the predictions by divid-
ing the number of TFs with existing supportive literature by
the total number of identified top regulators.
Identification of dynamic merged SEs
In order to identify temporal SEs across both lineages,
BedTools (41) version 2.24.0, Hypergeometric Optimiza-
tion of Motif EnRichment (27) (HOMER) version 4.7.2
and Short Time-series Expression Miner (42) (STEM)
version 1.3.8 were used. First, the coverage of individ-
ual SEs was summarized using genomeCoverageBed
command using --g mm10 and --bg parameters. Then,
unionBedGraphs command was used to combine mul-
tiple SEs coverage into a single map such that the SEs’
coverage is directly comparable across multiple samples.
At last, mergeBed command was used to combine
SEs overlapping ≥ 1 bp into a single merged SE which
spans all the combined SEs. In order to calculate the
normalized read count number of merged SEs, anno-
tatePeaks.pl with --size given and --noann
parameters was used. At last, STEM was used to cluster
and identify SEs temporal profiles and SEs with Maxi-
mum Unit Change in Model Profiles between Time Points
2 and Minimum Absolute Expression Change 1.0 were
considered as dynamic.
For the dynamic SEs we calculated the Pearson corre-
lation for the putative target genes with their TSS located
within ±500 kb, and associated the SEs to the genes with
the highest correlation coefficient.
Enrichment analysis
EnrichR (14.4.2017) (43,44) was used to perform gene en-
richment analysis.
RESULTS
A subset of differentially expressed genes are shared between
adipocyte and osteoblast differentiation
To identify shared regulators of differentiation toward
adipocytes and osteoblasts, and to delineate a general ap-
proach for a systematic unbiased identification of key reg-
ulators, we performed time-series ChIP-seq and RNA-seq
profiling at six different time points over 15 days of dif-
ferentiation of mouse ST2 cells (Figure 1A). Using ChIP-
seq, genome-wide profiles of three different histone mod-
ifications, indicating active transcription start sites (TSS)
(H3K4me3), active enhancers (H3K27ac) and on-going
transcription (H3K36me3) were generated. These data
were complemented by corresponding time-series RNA-
seq analysis. Importantly, at genome-wide level all the his-
tonemodifications showed good correlation with the RNA-
seq data across the time points (Pearson correlation co-
efficients of∼0.5), further arguing for the reproducibility of
the obtained results (data not shown). The successful differ-
entiations were confirmed by induced expression of known
lineage-specific marker genes and microscopic inspection
of cellular morphology and stainings (Supplementary Fig-
ure S1). Interestingly, profiles of the adipogenic marker
genes resembled those reported for the yellow adipose tissue
(YAT) found in the bone marrow, rather than classic white
adipose tissue (WAT) (45), consistent with ST2 cells orig-
inating from bone marrow stroma (Supplementary Figure
S1A). Moreover, the expression profiles of Sp7 and Runx2
were consistent to those previously reported for mouse os-
teoblasts (46).
Principal component analysis of the obtained transcrip-
tome profiles confirmed the specification of the cells toward
two different lineages with differential temporal dynamics
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(Figure 1B). Osteoblastogenesis was accompanied by grad-
ual and consistent progression toward a more differentiated
cell type while adipogenesis showed more complex dynam-
ics with a big transcriptome shift after one day of differ-
entiation, followed by a more gradual progression during
the following days. This is in keeping with the change in
the composition of the differentiation medium from day 2
onward (see ‘Materials and Methods’ section for details).
In total the adipocyte differentiation was characterized by
a total of 5156 significantly differentially expressed genes
(log2FC ≥ 1, FDR< 0.05) across the time series com-
pared to the undifferentiated cells (Figure 1C and Supple-
mentary Table S3). During osteoblast differentiation 2072
genes were differentially expressed at least at one time point.
A total of 1401 of these genes were affected in both lineages.
However, as illustrated by the top 100 genes with highest
variance across the time points, which are depicted in the
heatmap in Figure 1D, most genes exhibit either lineage-
specific or opposing behavior between the lineages. Only
a subset of genes showed similar changes in both lineages
(Figure 1D). Thus, narrowing the list of genes that could
serve as shared regulators of both differentiation or dedif-
ferentiation processes.
Unbiased data-driven derivation of context-specific dynamic
regulatory networks of adipocyte and osteoblast differentia-
tion using EPIC-DREM
In order to take an unbiased and data-driven approach that
can benefit from the time series profiles, we have developed a
new method to predict condition-specific TF binding using
footprint calling inH3K27ac data and TFmotif annotation
(35) (37). We previously found that using footprints works
well for the prediction of gene expression using TEPIC (19).
Our approach uses a randomization strategy, which accu-
rately accounts for differences in footprint lengths and GC-
content bias, to assess the significance of TF binding affinity
values for each condition or time point (Figure 2A; see ‘Ma-
terials and Methods’ section for more details). These time
point-specific predictions can be combined with theDREM
approach (5) to construct lineage-specific networks that are
supported by epigenetics data (called EPIC-DREM, Figure
2A).
At first we have used 78 TF ChIP-seq datasets from three
ENCODE cell lines (GM12878, HepG2 and K562) to test
the ability of our approach to prioritize condition-specific
TF binding sites using this pipeline. Using a P-value cut-
off < 0.05 we obtained accurate cell-type specific TF bind-
ing predictions with a median precision of ∼70% without
a major decrease in recall (Supplementary Figure S2) and,
thus, used the same cut-off for our time-series differentia-
tion data.
We used EPIC-DREM to analyze all timepoints of the
two differentiation time series of adipogenesis and os-
teoblastogenesis. Depending on the time point and lineage
we predicted 0.6 to 1.4 million footprints per time point,
consistent with previous reports on the presence of ∼1.1
million DNase-seq footprints per cell type (47). These foot-
prints were annotated with TFs that are expressed dur-
ing the differentiation and were associated to target genes
within 50 kb of their most 5′TSSs to obtain the TF scores
per gene and per time point (see ‘Materials and Meth-
ods’ section and Figure 2). The full matrix of the time
point-specific TF–target gene interactions per lineage can
be downloaded at doi:10.5061/dryad.r32t3.
The derived matrix of the predicted time point-specific
TF–target gene interactions was combined with the time
series gene expression data to serve as input for DREM
to identify bifurcation events, where genes split into paths
of co-expressed genes (Figures 2 and 3). Knowing the time
point-specific TF–target gene interactions allows an accu-
rate association of split points and paths with the key TFs
regulating them. To directly test the accuracy and the bi-
ological relevance of the EPIC-DREM predictions com-
pared to alternative methods, we performed the same anal-
ysis of the time-series expression data also with three al-
ternative approaches for the prediction of TF–gene interac-
tions: (i) based onDREM2.0, using existing, time-point un-
specific ChIP-seq datasets of TF binding sites; (ii) DREM-
TRAP, where the TF binding site predictions are com-
puted in 2 kb windows centered at the gene TSSs without
the time- and context-specific epigenomic profiles, and; (iii)
Random shuffling of the EPIC-DREM TF–gene interac-
tion matrix (Figure 2B and C). To address the biological
relevance of these predictions, we considered the top 15 TFs
with best split scores from each split at day 0 and combined
them into lists of potential master regulators identified for
both lineages and each prediction method (Figure 2B and
Supplementary Table S4). Next we performed a literature
search for each of the predicted TFs on these lists to see
whether they have already been associated with adipogen-
esis or osteoblastogenesis (Supplementary Table S4). From
the randomly assigned TFs only 20–30% had been previ-
ously found to be associated with the two cell types, while
for the TFs predicted by the time-point unspecific methods
DREM 2.0 or DREM-TRAP this fraction increased to be-
tween 53% and 59%, depending on the lineage (Figure 2B).
However, applying EPIC-DREM for the prediction further
improved the fraction of biologically relevant known TFs
to as high as 92% for adipocyte and 74% for osteoblast dif-
ferentiation, respectively. Consistently, the DREM enrich-
ment scores obtained by EPIC-DREM were overall higher
than those obtained by the other methods (Figure 2C), in-
dicating that the TFs identified by EPIC-DREM can much
better explain the observed expression dynamics.
DREM clusters co-expressed genes along the time-points
and identifies split points with transcriptional regulators
assigned to them. Figure 3 shows the split points and the
paths of co-expressed genes identified for adipocyte (Fig-
ure 3A) and osteoblast (Figure 3B) differentiation. The en-
tire predicted gene regulatory networks consist of up to
tens of thousands of nodes and edges, preventing their
illustration in an intuitive fashion. However, for the se-
lected DREMpaths the TF–TF networks of the top 25 TFs
(based on their split score) are illustrated in Figure 3, with
the size of the TF nodes corresponding to the total num-
ber of time point-specific predicted target genes across the
genome. The full list of TFs controlling the individual paths
are provided in Supplementary Table S5 and the full ma-
trix of the gene regulatory networks can be downloaded at
doi:10.5061/dryad.r32t3.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/advance-article-abstract/doi/10.1093/nar/gky1240/5245443 by Lasse Sinkkonen on 14 D
ecem
ber 2018
10 Nucleic Acids Research, 2018
GLIS1
HIF1A
KLF13
CHD2
KLF16
KLF7
TBX15
SP8
NR4A3
CENPB
RXRB
FOXN1
NFIC
E2F6
AHR
CXXC1
HES1
TEAD2 RELB
MBD2
ARNT
HIF1A
HLTF
KLF5
AHR_ARNT
E2F5
HMGN3
GMEB1
FOXN1
E2F1
HES1
HINFP
MZF1
MEIS1
E4F1MITF
TEAD2
IKZF2
ZBTB14NR3C2
NR3C1
MECP2THAP1
CREB1
BATF
JUN
HLTF
BACH1
MAFK
BHLHE40
NR2F1
CENPB
D1 D3 D5 D9 D15
Days of osteoblast differentiation
LHX1
NR2F1 ALX4
POU6F1
ZBTB33
CEBPA HOXB4
MLXIP
LEF1RFX7
ARNT2
ESR2
ZFHX3
ESR1
NPAS2 NFYC
FOXC1HOXC5HOXA3
FOXF2
GMEB2
CEBPZ
HERPUD1
OVOL1
GMEB1
FOXK1
TBX20
MEIS1
CREB
TGIF1
GLIS1
TBR1
NFYC
STAT1
STAT2
NFIC
TLX1
MEIS2
GLI3
MAFG
NFE2L1
FOXF2
ZBTB7A
ZBTB7C
NR2C2
ARNT
BATF
JUN
TGIF2
FOXN1
E2F1HES1
CREB3
E2F3
ETV6TFAP2A
ARNT
HIF1A
ZBTB14
ETS2
ZBTB33
AHR
ARNT
SP4
BARX2AHR GATA6
TFAP2B
(VAR2)
CXXC1
LIN54
ZBTB6 HOXA7
ZBTB7A TFAP2C
(VAR3)
TFAP2B
(VAR3)
TFAP2C
(VAR2)
0 - 2000
>6000
>8000
>10000
>4000
>2000
0 - 2000
>6000
>8000
>10000
>4000
>2000
8
7
6
5
4
3
2
1
0
0
-1
-2
1
2
3
4
5
-1
-2
-3
R
el
at
iv
e 
ex
pr
es
si
on
 (
lo
g 2
)
R
el
at
iv
e 
ex
pr
es
si
on
 (
lo
g 2
)
Upregulated
Downregulated
Upregulated
Downregulated
Day 0 Day 1 Day 3 Day 5 Day 9
AHR::ARNT 
CXXC1 
E2F4 
FOXN1
O
v
e
rl
a
p
 o
f 
to
p
 2
0
 
re
g
u
la
to
rs
 (
p
e
r 
ti
m
e
 p
o
in
t)
A
D
IP
O
G
E
N
E
S
IS
S
H
A
R
E
D
O
S
T
E
O
B
L
A
S
T
O
G
E
N
E
S
IS
911 11
GLIS1 
HIF1A 
MBD2 
TEAD2 
ZBTB33 
E2F1 
FOXN1
GMEB1
HINFP
416 16 020 20
SETDB1
119 19
Ad
Ob
Ad
Ob
Ad Ad
Ob Ob
Day 0 Day 1 Day 3 Day 5 Day 9 Day 15
Day 0 Day 1 Day 3 Day 5 Day 9
Day 15
N
um
be
r 
of
 p
re
di
ct
ed
 ta
rg
et
s
N
um
be
r 
of
 p
re
di
ct
ed
  t
ar
ge
ts
A
B
C
Figure 3. Derivation of lineage-specific regulatory interactions using EPIC-DREM. EPIC-DREM clusters genes into paths of similar expression over time
in (A) adipocyte and (B) osteoblast differentiation. Split points differentiate time point-specific changes in gene expression, that are annotated by DREM
with matching TFs based on the predicted TF–target gene interactions. For each such path a GRN of thousands of interactions has been derived. The
top TFs based on their time point- and path-specific split scores can be used to generate TF–TF networks underlying the observed gene regulation. The
TF–TF networks of top 25 TFs are indicated for (A) three selected paths in adipocyte and (B) two selected paths in osteoblast differentiation. The top
TFs are colored depending whether they are upregulated (blue) or downregulated (orange) compared to undifferentiated cells and the size of the node
corresponds to the total number of predicted target at the indicated time point. The full set of TFs predicted to control each path with at least 30% of the
genes in the upstream split point with a split score ≤ 0.01 are listed in Supplementary Table S5. (C) Overlap of the time point-specific top TFs between
the lineages. For both lineages lists of top 20 TFs per time point were generated by combining the predictions from individual splits. The Venn diagrams
indicate the extent of overlap between the lineage-specific top TFs at each time point and the shared top TFs are indicated.
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Inspection of the TF–TF networks of the identified top
TFs confirmed many known positive (e.g. KLF5 on day
0, CEBPA on D1 and TGIF2 on D3) and negative (e.g.
HES1 and NR4A3 on day 0, FOXC1 on D1) regulators of
adipocyte differentiation (48–51) (Figure 3A), consistently
with the above-mentioned findings that most of the top
TFs have been associated with adipogenesis in the literature
(Supplementary Table S4). Focusing on the size of the indi-
vidual nodes in the TF–TF networks directly reveals that
TFs controlling the first time point directly after differen-
tiation initiation have the highest number of predicted tar-
get genes, with some TFs such as HES1 having more that
10 000 predicted target genes (Figure 3A). Similarly, the re-
sults of the regulatory network of osteoblastogenesis con-
firms several known positive regulators such as the afore-
mentioned HES1, TEAD2 and BHLHE40 (52–54), while
revealing many other factors that have not been previously
associated to osteoblast differentiation (Figure 3B).
Curiously, EPIC-DREM analysis did not highlight TFs
such as PPARG among the top 25 TFs at any bifurcation
point, despite PPARG being a well-established master reg-
ulator of adipocyte differentiation (55). To better under-
stand this result and to further explore capabilities of EPIC-
DREM we had a detailed look at the predictions related to
PPARG and the PPARG:RXRA heterodimer. Indeed, both
the PPARGmonomer and the heterodimer with RXRA ap-
pear among the predicted regulators at most split points
(see Supplementary Table S5), in particular for the paths
of genes upregulated in adipogenesis. The highest ranking
of PPARG is obtained for the genes induced directly af-
ter differentiation initiation on day 0, where it is ranked as
TF number 34 based on the split score. To better illustrate
PPARG regulation in yellow adipocyte differentation, we
generated a PPARG-centric GRN on day 3 of differentia-
tion (Supplementary Figure S3), the time point where the
highest induction ofPpargmRNA takes place (Supplemen-
tary Figure S1). Supplementary Figure S3 shows all the TFs
predicted to control Pparg expression at this time point and
the top 200 targets out of the total of 3405 genes predicted
to be regulated by PPARG:RXRA (Supplementary Table
S6). To see whether these predicted targets are consistent
with known direct target genes, we used results from Left-
erova et al. who experimentally identified PPARG targets as
genes with at least 3-fold change in their expression in differ-
entiated adipocytes and with binding of PPARG within 50
kb from the TSS based on ChIP-seq data (56). Importantly,
our predicted PPARG:RXRA targets were significantly en-
riched for these experimentally validated targets (hypergeo-
metric test P = 2.78e-31).
The fact that PPARG is missing from the lists of the
very top TFs explaining the gene expression dynamics dur-
ing adipogenesis could be due to its modest induction dur-
ing ST2 cells differentiation (Supplementary Figure S1).
Indeed, Pparg was noted already in earlier work to be
weaker induced in bone marrow derived ST2 cells than in
the 3T3-L1 cells that are more commonly used to study
white adipocyte differentiation (57). In keeping with these
observations, analysis of the histone modifications associ-
ated with active transcription at the Pparg locus in pub-
lished data from 3T3-L1 cells confirmed the appearance
of strong enhancers (based on H3K27ac signal), increased
transcription (H3K36me3) and activation of both alterna-
tive transcription start sites (H3K4me3) after differentia-
tion initiation (Supplementary Figure S4; (58)). In con-
trast, in ST2 cells Pparg transcription was abundant al-
ready prior to differentiation (H3K36me3), with only one
TSS marked by H3K4me3 (transcript variant 1) and strong
enhancer regions active across the locus (H3K27ac) (Sup-
plementary Figure S4A). Moreover, while also SE regions
could be identified at the Pparg locus, consistently with pre-
vious work (9), these did not change significantly during
differentiation. Thus, our data confirms PPARG as an im-
portant SE-controlled regulator with thousands of putative
targets in bone marrow-derived ST2 cells and adipocytes
differentiated from them, albeit with only modest changes
during differentiation.
To see whether the more modest Pparg induction is
unique to the ST2 cell line or whether it is a general fea-
ture of multipotent bone marrow progenitors, we inspected
recently published RNA-seq and ChIP-seq from primary
mouse bone marrow-derived mesenchymal stem cells and
from adipocytes and osteoblasts differentiated from them
(18). Also in the primary bone marrow-derived cells Pparg
induction remained lower than in 3T3-L1 cells with 3-
to 4-fold increase after 7 days of adipogenesis, with only
TSS of transcript variant 1 marked by H3K4me3 and en-
hancer signals marked by H3K9ac and H3K4me1 increas-
ing at regions corresponding to Pparg SE in ST2 cells (Sup-
plementary Figure S4, see ‘Materials and Methods’ sec-
tion for UCSC Genome Browser link for the uploaded
data from (18)). Thus, Pparg regulation in primary bone-
marrow derived cells resembles that in ST2 cells, albeit with
stronger induction in histone modifications indicating tran-
scriptional activity upon differentiation.
One of our main aims in analyzing two parallel lin-
eages was the identification of shared regulators that could
control the differentiation or dedifferentiation of both cell
types. With this aim in mind, we combined the predictions
from all bifurcation points per time point to generate sepa-
rate lists of top 20 TFs with most targets for each time point
in both lineages (Figure 3C, see ‘Materials and Methods’
section). Next the top 20 TFs at corresponding time points
in both lineages were overlapped to uncover the extent and
identity of the shared top TFs. As might be expected, the
highest level of overlap between the regulators was observed
at early differentiation with 9 out of 20 top TFs being same
for both lineages (Figure 3C). These are likely to include
TFs important for maintaining the multipotent state of the
cells and thus, negative regulators of both differentiation
processes. Indeed, TFs like the AHR:ARNT heterodimer,
E2F4, GLIS1, HIF1A, and TEAD2 have already been as-
sociated with gene regulation in different stem cell types
(59–65). Interestingly, at day 1 of differentiation the num-
ber of shared TFs decreases to four and at later time points
the only shared factor is SETDB1, better known as a co-
regulator (66). The only TF to appear as shared regulator
at two different time points is FOXN1, which is highly con-
nected inGRNs of both lineages, strongly downregulated in
adipogenesis but highly expressed in osteoblasts, suggesting
FOXN1 might play opposite roles in the two lineages (Fig-
ure 3 and Supplementary Table S3).
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Taken together, the EPIC-DREM approach can identify
many known key regulators of adipocyte and osteoblast dif-
ferentiation and predicts additional novel regulators and
the bifurcation events they control in an entirely unbiased
manner relying only on the available time series data.
Identification of dynamic SEs in adipocyte and osteoblast dif-
ferentiation
EPIC-DREM can efficiently identify the main regulators
of the differentiation time courses that control the high-
est numbers of target genes at each time point and that
can best explain the observed expression dynamics. How-
ever, prioritizing the identified TFs also through an alter-
native approach that relies on different criteria is often de-
sirable. In order to take a parallel approach to further nar-
row down the identified main regulators, we hypothesized
that the key TFs of the differentiation processes would be
under high regulatory load and controlled by SEs with dy-
namic profiles. To obtain such profiles of SEs across time
points, we first identified all SEs with a width of at least 10
kb separately in each of the 10 H3K27ac ChIP-seq datasets
from the two time courses. Next, to allow a quantification
of the SE signals across time, while also accounting for the
changes in the width of the SEs, we combined all SEs from
all time points with at least 1 nt overlap into one broader
genomic region, called a merged SE. Figure 4A illustrates
how the 49 SEs found at the Cxcl12 locus, producing a
chemokine essential for maintenance of the hematopoietic
stem cells (HSCs) (16), can be combined into one exception-
ally large merged SE region that enables the quantification
of the SE signal across time. The normalized read counts in
the merged SE region were collected and normalized rela-
tive to D0 (Figure 4B). To confirm that the obtained profile
is a reasonable estimate of the SE activity and to see whether
it could indeed be regulating theCxcl12 gene expression, we
compared the SE signal profiles to the Cxcl12 mRNA pro-
files. As shown in Figure 4B, in both lineages the SE signal
closely followed the mRNA expression profile with Pear-
son correlation coefficients of 0.83 and 0.89, respectively.
Moreover, similar correlations could be seen for most other
identified merged SEs, further confirming the applicability
of our approach.
In total, we identified 1052 merged SEs across the two
lineages (Supplementary Table S7). A total of 120 and 79
merged SEs showed a dynamic profile (log2FC≥ 1 in at least
one time point) in adipocyte and osteoblast differentiation,
respectively. Of these, 25 dynamic SEs showed concordant
changes in both differentiation processes (Figure 4C–E and
Supplementary Table S8). Consistent with the different dy-
namics in transcriptomic changes (Figure 1), the adipocyte
SEs could be divided into four separate main profiles based
on their dynamics (Figure 4C and Supplementary Figure
S5) while most osteoblast SEs could be assigned into one of
two simple profiles that either increase or decrease in signal
over time (Figure 4D).
In order to identify the genes regulated by these dynamic
SEs we calculated the Pearson correlation for all of the dy-
namic SEs and all of their putative target genes with their
TSS located within ±500 kb, and associated the SEs to
the genes with the highest correlation coefficient (Supple-
mentary Table S8). Out of the 151 genes we found to be
associated with the dynamic SEs within the defined dis-
tance, 12 were known regulatory genes, classified either
as TFs (67) or microRNA genes (Figure 4E). From the
12 regulatory genes, 7 were associated with SEs dynamic
only in adipogenesis, namely, Creb5, Hoxc13, Hsf2, Trp63,
Trps1, Zhx3 and Foxn1. From these FOXN1 was already
highlighted among the top TFs by EPIC-DREM analysis,
while HOXC13 and HSF2 were also predicted to regulate
genes induced during adipogenesis (Supplementary Table
S5). The regulatory genes associated with SEs dynamic only
in osteoblastogenesis were Nfe2l1 and miR-322/503. From
these NFE2L1 was induced and, together with its dimeriza-
tion partnerMAFG, predicted by EPIC-DREMas positive
regulator of both osteoblast and adipocyte differentiation
(Figure 3 and Supplementary Table S5), while miR-322 and
miR-503 have been shown to enhance osteogenesis (68,69).
Finally, three of the regulatory genes, aryl hydrocarbon re-
ceptor (Ahr), GLIS family zinc finger 1 (Glis1), and Home-
obox A10 (Hoxa10), were associated with SEs dynamic in
both lineages (Figure 4E). Interestingly, all three TFs are
predicted as regulators of differentiation by EPIC-DREM
(Supplementary Table S5), and both AHR and GLIS1 be-
long to the top TFs found to be shared between the two
lineages (Figure 3C). AHR, the AHR:ARNT heterodimer
andGLIS1 belong to the TF–TF network controlling genes
in early adipogenesis and depicted in Figure 3A. In addition
GLIS1 is also included in the TF–TF network controlling
genes induced on day 3 of adipogenesis. Similarly, AHRand
AHR:ARNT are found in the TF–TF network controlling
genes after day 1 of osteoblastogenesis (Figure 3B). More-
over, Ahr is associated with four separate merged SEs, more
than any other TF in our analysis, and predicted to function
upstream ofGLIS1 in the undifferentiated cells (Figures 3A
and 4E). Therefore, we next focused on Ahr and Glis1 regu-
lation.
Ahr and Glis1 are controlled by SEs in undifferentiated ST2
cells and repressed with lineage-specific dynamics
The four adjacent merged SEs (SE283, SE284, SE285, and
SE286) at the Ahr locus together cover a continuous region
over 300 kb of active enhancer signal downstreamof theAhr
gene in the ST2 cells (Figure 5A and B). SE831 covers a re-
gion of 29 kb in the 3′end of the Glis1 gene in the same cells
(Supplementary Figures S6A and B). All four SE regions at
theAhr locus follow similar dynamics across the time points
(Figure 5A–D) although SE283 was identified as being dy-
namic only in adipogenesis due the FC cut-off in the initial
analysis in Figure 4. Moreover, all four SEs showed a very
high correlation (r ≥ 0.95) with Ahr mRNA levels as mea-
sured by RNA-seq (Figure 5C and D, upper panels) and
validated by RT-qPCR (Figure 5C and D, lower panels). In
adipogenesis Ahr expression is repressed already by D1 and
remains repressed throughout the differentiation, while the
signal from all the SE regions is also becoming reduced al-
ready after 1 day. In contrast in osteoblasts, the SE regions
first show an increase in signal on D1, followed by gradual
reduction fromD3 onward, consistent with theAhrmRNA
levels.
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Figure 4. Identification of dynamic SEs. (A) Overview depicting the enrichment of H3K27ac at the Cxcl12 locus across the time points of adipogenesis
(in magenta) and osteoblastogenesis (in light blue). The magenta and light blue bars indicate the SE regions identified by HOMER in adipogenesis and
osteoblastogenesis, respectively, and black bar indicates the merged SE derived through overlapping of the individual SEs across the lineages. (B) The
correlation between mRNA levels and SE signal. The Cxcl12 mRNA levels as measured by RNA-seq and the merged SE signal at the Cxcl12 locus as
measured by the reads detected in the H3K27ac IPs are depicted across the time-series of adipocyte (upper panel) and osteoblast (lower panel) differenti-
ation. Intact line = mRNA level and dashed line = merged SE signal. r = Pearson correlation co-efficient (C and D) STEM clustering of the merged SEs
according to their dynamic profiles identifies (C) four main profiles in adipogenesis and (D) two main profiles in osteoblastogenesis. The additional profiles
are shown in Supplementary Figure S5. y-axis indicates the signal change in log2-scale. (E) Venn analysis of the dynamic merged SEs from both lineages
identifies 95 adipocyte-specific, 54 osteoblast-specific and 25 shared dynamic SEs with log2FC ≥ 1. The dynamic SEs were associated to their target genes
based on Pearson correlation with gene expression levels across the time series and the regulatory genes (TFs and miRNAs) associated with dynamic SEs
are indicated in the corresponding boxes. All dynamic SEs and their putative target genes are listed in Supplementary Table S8. Adipocyte D9 sample for
H3K27ac was not included in the above analysis due to low number of mappable high quality reads.
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Figure 5. Ahr is regulated by multiple SEs with lineage-specific dynamics. (A and B) Overview depicting the enrichments of H3K4me3 (in dark blue and
purple), H3K36me3 (in light and dark green) and H3K27ac (magenta and light blue) at the Ahr locus across the time points of adipogenesis (A) and
osteoblastogenesis (B), respectively. The magenta and light blue bars indicate the merged SE regions identified through the analysis described in Figure 4.
See also Supplementary Figure S7. (C andD)Ahr downregulation correlates with a decreased signal from all four SEs. TheAhrmRNA level was measured
across the differentiation by RNA-seq (upper panel) and RT-qPCR (lower panel) in both adipocyte (C) and osteoblast (D) differentiation and is indicated
as the intact line. Dashed lines represent the signal from the individual indicatedmerged SEs. r= Pearson correlation co-efficient. The statistical significance
for RT-qPCR measurements compared to the value on D0 was determined by two-tailed Student’s t-test. * = P < 0.05, ** = P < 0.01 and *** = P <
0.001. Data points represent mean of three biological replicates ±SEM. AD9 sample for H3K27ac and OD15 for H3K4me3 were not included in the
above analysis due to lower number of mappable high quality reads. (E) Overview depicting the enrichment of H3K27ac at the Ahr locus in the confluent
undifferentiated (D0) and differentiated (D7) 3T3-L1 adipocyte cell line. No SE formation could be detected in these more lineage-committed cells. The
data were obtained from (58). The H3K27ac enrichments at the corresponding locus in human cell types are indicated in Supplementary Figure S8A.
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Similarly, the Glis1 expression changes show high corre-
lation (r≥ 0.95) with the signal of SE831 in both lineages and
with both RNA-seq and RT-qPCR (Supplementary Fig-
ure S6C and D). While in osteoblast differentiation Glis1
is gradually decreased, in adipocyte differentiation a more
dynamic pattern of downregulation is observed with a tem-
porary induction on day 5.
At last, for both genes and in both lineages the repression
is accompanied by a decreased signal of H3K36me3 in the
gene bodies of the two genes, confirming their repression
at the transcriptional level (Figure 5A and B; Supplemen-
tary Figure S6A and B). RNA-seq and H3K36me3 ChIP-
seq from primary mouse bone marrow-derived mesenchy-
mal stem cells and from adipocytes and osteoblast differen-
tiated from them further confirmed the downregulation of
Glis1 in both lineages and of Ahr in adipogenesis (see ‘Data
Availability’ section forUCSCGenomeBrowser link for the
uploaded data from Meyer et al. (18)). In osteoblastogene-
sis the decrease of Ahr was not confirmed, possibly due to
differences in the used differentiation protocols.
While the newly identified SE clusters at theAhr locus are
also flanked by another active gene,Snx13, it is unlikely that
the SEs contribute to its regulation; during the two differen-
tiations Snx13 shows very few changes in its expression or
H3K36me3 signal (Figure 5A and B and data not shown).
Moreover, inspection of Hi-C data surrounding the Ahr lo-
cus in different mouse cell types indicates that Ahr and the
four SEs are located in their own topological domain (TAD)
separate from the Snx13 gene (Supplementary Figure S7)
(70). Similarly, SE831 could be confirmed to be located in
the same TADwithGlis1 and the neighboringDmrtb1 gene,
which is silenced in the ST2 cells, suggesting thatGlis1 is the
main target of the SE.
Interestingly, the SEs controlling Ahr and Glis1 appear
to be specific for the multipotent cells as only weak or no
H3K27ac signal could be detected in the corresponding ge-
nomic region inmouse 3T3-L1 pre-adipocytes that aremore
committed toward the white adipocyte lineage (Figure 5E
and Supplementary Figure S6E, (58)). Moreover, the SE re-
gions at both genes were enriched for additional enhancers
marks, H3K4me1 and H3K9ac, in primary mouse bone
marrow-derived mesenchymal stem cells (see ‘Data Avail-
ability’ section for UCSC Genome Browser link for the up-
loaded data from Meyer et al. (18)). Importantly, the large
SE domains downstream of the Ahr gene and the enhancer
signals at the 3′end of Glis1 could be identified also in hu-
man mesenchymal stem cells, but not in other inspected hu-
man cell types, suggesting that the complex regulation of
Ahr andGlis1 expression in these multipotent cells could be
conserved and relevant also in human development (Sup-
plementary Figure S8).
Overexpression of AHR and GLIS1 can inhibit bone marrow
stromal progenitor differentiation
Based on the above results, we reasoned that Ahr and Glis1
could play important roles in maintaining mesenchymal
bone marrow progenitors in a multipotent state. Indeed,
previous work has separately shown that both adipogene-
sis and osteoblastogenesis can be inhibited by toxic com-
pounds like dioxin that are xenobiotic ligands of AHR (71–
73), while GLIS1 has been shown to promote reprogram-
ming of fibroblasts to induced pluripotent stem cells (iPSCs)
(61).
To investigate whether a failure to downregulate AHR
or GLIS1 upon differentiation would interfere with the lin-
eage commitment, we generated stable doxycyclin inducible
ST2 cell lines capable of overexpressing AHR or GLIS1
(ST2-TetOn-AHR and ST2-TetOn-GLIS1 cells, see ‘Mate-
rials and Methods’ section for details). As control cells, in-
ducible CopGFP expressing cell lines were generated (ST2-
TetOn-GFP). To test the inducibility of the generated cell
lines, the expression of CopGFP was observed via fluores-
cencemicroscopy. As shown in Figure 6A, 24 h treatment of
the generated ST2-TetOn-GFP cell lines with doxycycline
(Dox+) was able to induce high levels of GFP expression.
Next all the generated cell lines were differentiated to-
ward adipocytes or osteoblasts either in presence (Dox+)
or absence (Dox−) of doxycycline and RNA and protein
were collected at D5 or D9 of differentiation. The signif-
icantly and strongly induced levels of both Ahr and Glis1
expression could be confirmed by RT-qPCR during differ-
entiation in the respective cell lines under Dox+ conditions
(Figure 6B). However, for both TFs elevated expression lev-
els of the inserted TFs were also detected in the Dox− con-
ditions, suggesting existing activity of the Tet-On 3G pro-
moter also in the absence of doxycycline. At last, to directly
test the increased TF expression at the protein level, western
blotting for samples from the same conditions was carried
out (Figure 6C). AHRwas confirmed to be elevated in ST2-
TetOn-AHR cells both in Dox− and Dox+ conditions, with
a particularly high induction visible in the presence of doxy-
cycline. For GLIS1 none of the available tested antibodies
were found to be specific (data not shown).
To directly assess the impact of the AHR and GLIS1 ex-
pression on the adipocyte differentiation of the ST2 cells, we
performed Oil Red O staining of lipid accumulation on the
D5 andD9 of adipogenesis. While ST2-TetOn-GFP control
cells showed some accumulation of lipids already on D5, as
indicated by the faint red staining, no such staining could be
observed in ST2-TetOn-AHR or ST2-TetOn-GLIS1 cells at
the same time point (Figure 6D). Moreover, this difference
became even clearer on D9 of differentiation when the con-
trol cells showed strong red staining of the lipids in both
Dox+ and Dox− conditions, while in AHR expressing cells
only modest lipid accumulation could be observed in Dox−
condition, and no accumulation at all in the Dox+ condi-
tion. Also GLIS1 expressing cells did not show additional
lipid accumulation after D5. However, this could not be
confirmed by Oil Red O staining as in particular the GLIS1
expressing cells were loosing their adherence along the pro-
gression of the differentiation.
To confirm the observed differentiation defects in the
presence of highAHRandGLIS1 levels, RT-qPCRanalysis
of the known adipocyte marker gene Lplwas performed. In
ST2-TetOn-GFP cells Lpl was upregulated by D5 of differ-
entiation and remained elevated inD9 cells both in presence
and absence of doxycycline (Figure 6E). However, consis-
tently with the Oil Red O staining results, the ST2-TetOn-
AHR cells showed reduced induction already in Dox− con-
ditions and no induction at all upon additional AHR over-
expression. Similarly, GLIS1 overexpressing cells failed to
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Figure 6. Ahr and Glis1 inhibit the differentiation of multipotent ST2 cells. (A–C) Establishment of stable inducible AHR and GLIS1 expressing ST2 cell
lines. (A) Control cell lines with integrated CopGFP gene under a Tet-On 3G promoter (ST2-TetOn-GFP) can be induced for GFP expression by DOX
treatment for 24 h. (B) Stable ST2 cell lines with integrated Ahr gene (ST2-TetOn-AHR) or Glis1 (ST2-TetOn-GLIS1) gene under TetOn 3G promoter
overexpress AHR and GLIS1, respectively. ST2 cell lines were differentiated for 5 days (D5) or 9 days (D9) toward adipocytes (in magenta) or osteoblasts
(in light blue) in the presence or absence doxycycline (Dox+ or Dox−) and RT-qPCR was performed for Ahr and Glis1 to test for TF overexpression
compared to the differentiated ST2-TetOn-GFP cell lines. Glis1 primers were specific for the inserted codon-optimized Glis1 sequence and do not detect
the endogenous Glis1 mRNA. Therefore no normalization to the ST2-Tet-On-GFP cells could be performed. The statistical significance for RT-qPCR
measurements compared to the value in the similarly differentiated ST2-TetOn-GFP cells (for Ahr) or ST2-TetOn-GLIS1 (for Glis1) was determined by
one sample t-test. * = P < 0.05, ** = P < 0.01 and *** = P < 0.001. Data points represent mean of three independent stable cell lines ± SEM. (C)
Western blot analysis of AHR expression in ST2-TetOn-AHR cells and ST2-TetOn-GFP cells on D5 and D9 of differentiation toward adipocytes (upper
panel) or osteoblasts (lower panel) in presence (Dox+) or absence (Dox−) of doxycylin. No GLIS1 Western blot was performed due to lack of a specific
antibody. (D) Inhibition of adipocyte differentiation by overexpression of AHR or GLIS1. Oil Red O staining of the indicated ST2 cell lines on D5 and
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induce Lpl expression, indicating a failure to differentiate
toward adipocytes.
Next, the impact of the two TFs on osteoblast differenti-
ation was investigated by RT-qPCR analysis of the known
osteoblast marker gene Sp7. Again the ST2-TetOn-GFP
cells showed strong upregulation of Sp7 by D5 of differenti-
ation and remained somewhat elevated onD9 of differentia-
tion (Figure 6F). To our surprise, the presence of the doxy-
cycline in the differentiation culture further increased the
Sp7 induction, indicating that doxycycline alone might in-
fluence osteoblast differentiation. Indeed, existing literature
indicates a role for tetracyclines as positive regulators of
bone formation and osteoblast differentiation via their ef-
fects onmetalloproteinases andWnt signaling (74,75). Also
in ST2-TetOn-AHR cells the presence of doxycycline was
increasing the Sp7 expression upon induction of differenti-
ation, complicating the conclusion on AHR’s effect on os-
teoblastogenesis. However, in ST2-TetOn-GLIS1 cells the
significant induction of Sp7 on D5 in the absence of doxy-
cycline was completely lost upon GLIS1 overexpression,
indicating that GLIS1 expression inhibits also osteoblast
differentiation. Moreover, the GLIS1 overexpressing cells
were undergoing increased levels of cell death specifically in
osteoblast differentiating cells, preventing the collection of
samples after D5 of differentiation (data now shown). Con-
sequently, also von Kossa staining for mineralization of the
mature osteoblasts could not be performed with these cells.
AHR and GLIS1 regulate mesenchymal multipotency
through repression of lineage-specific genes
Given the impact of AHR and GLIS1 overexpression on
ST2 differentiation, we wanted to interrogate whether also
the endogenous TFs could directly influence the multipo-
tent state of the bone marrow progenitor cells, and what are
their target genes. Therefore we performed a knock-down
(KD) of the endogenous AHR and GLIS1 in the ST2 cells
and tested the expression of lineage-specific marker genes
used earlier to confirm differentiation (Figure 7A; Supple-
mentary Figures S9A–C and S1). For AHR a KD of ∼50%
could be confirmed at both mRNA and protein level, while
Glis1 reduction was around 30% and could not be con-
firmed at the protein level due to lack of a specific antibody.
Still, GLIS1-KD led to a modest but significant induction
of Cebpa, Lpl and Bglap expression, while AHR-KD af-
fected the Lplmarker gene, consistent with the previous re-
sults from the overexpression experiments. Thus, bothAHR
and GLIS1 might contribute to maintenance of the multi-
potent state.
While AHR is best known for its role as a xenobiotic re-
ceptor, it has been recently suggested that it could also play
a role in stem cell maintenance inHSCs under the control of
endogenous ligands (76). Moreover, since GLIS1-KD was
not more robust and could not yet be confirmed on the pro-
tein level, we next focused on the AHR-KD. To directly test
whether the endogenous activity of AHR is important for
themaintenance of the appropriate transcriptional program
of the ST2 cells, we knocked downAHR in undifferentiated
cells, and those differentiated for one day toward either lin-
eage (Figure 7B and Supplementary Figure S9B). Two days
following the KD total RNA was extracted and subjected
to RNA-seq analysis.
The number of genes affected by the AHR-KD (FDR
≤ 0.1) compared to the respective control siRNA transfec-
tions was greatly dependent on the cellular condition and
ranged from 614 genes in the undifferentiated cells to 722
and 1819 genes in the one day differentiated osteoblasts and
adipocytes, respectively (Figure 7C and Supplementary Ta-
ble S9). The higher extent of genes affected in the differ-
entiated cells is well in keeping with the number of genes
normally changing in the early osteoblasto- or adipogene-
sis, with adipogenesis associated with more changes (Figure
1). This suggests that early changes induced by the knock-
down in the undifferentiated cells are amplified in the dif-
ferentiating cells.
At first, we took advantage of these context-specific KD
data to ask whether the EPIC-DREM predicted primary
AHR targets at the corresponding time points were indeed
affected by depletion of AHR. As shown in Figure 7D, at
each condition the predictedAHR targets were significantly
more affected by AHR-KD than all genes on average. Es-
pecially the top genes with highest affinity scores for AHR
regulation on day 1 of adipogenesis were clearly shifted to-
ward more upregulation at each condition (to the right in
the cumulative distribution plot), arguing for functional rel-
evance of the EPIC-DREM predictions and for AHR’s role
as transcriptional repressor. As highlighted earlier in Figure
3A, AHR was predicted by EPIC-DREM to act as a direct
regulator of Glis1 in undifferentiated cells and during early
adipogenesis. To test this specific prediction we performed
RT-qPCR forGlis1 in all AHR-KD samples and confirmed
a significant change in Glis1 levels upon AHR depletion
in both differentiating adipocytes and osteoblasts (Figure
7E, left panel). However, AHR overexpression failed to in-
duce consistent effects onto Glis1 levels in the undifferenti-
ated ST2-TetOn-AHR cells (Figure 7E, right panel). Inter-
estingly, GLIS1 overexpression did induce Ahr levels in the
undifferentiated ST2-TetOn-GLIS1 cells (Figure 7E, right
panel), thereby suggesting existence of feedback regulatory
loops that will require further analysis.
To better understand the function of the putative AHR
target genes in the ST2 cells, we overlapped the differen-
tially expressed genes from the undifferentiated cells with
those identified in the two other KD experiments and ob-
tained 266 high-confidence target genes that were affected
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
D9 of differentiation. No staining of ST2-TetOn-GLIS1 cells could be performed on D9 due to decreased adherence of the cells. (E and F) Changes in (E)
adipogenesis and (F) osteoblastogenesis marker genes upon TF overexpression. ST2 cell lines were differentiated for 5 days (D5) or 9 days (D9) toward
adipocytes or osteoblasts in the presence or absence of doxycycline (Dox+ or Dox−) and RT-qPCR was performed for (E) Lpl and (F) Sp7. The expression
in the undifferentiated (D0) ST2-TetOn-GFP cells was set to 1 and is indicated by the dashed line. The statistical significance for RT-qPCR measurements
compared to the value in the undifferentiated ST2-TetOn-GFP cells was determined by one sample t-test. * = P < 0.05, ** = P < 0.01 and *** = P <
0.001. Data points represent mean of 3 independent stable cell lines ± SEM.
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Figure 7. AHR and GLIS1 KDs lead to induction of lineage-specific genes and confirm EPIC-DREM predicted AHR targets. (A) Relative expression
levels of differentiation marker genes following AHR or GLIS1 KD in undifferentiated ST2 cells are shown (y-axis). The statistical significance for RT-
qPCRmeasurements of KD cells against cells transfected with siControl was determined by a two-tailed Student’s t-test (* = P< 0.05, ** = P< 0.01 and
*** = P < 0.001). Data points represent mean of three biological replicates ± SEM. (B) Schematic representation of the KD RNA-seq experiments. See
Supplementary Figure S9 for more details on KD efficiency. (C) Venn diagram comparing the differentially expressed genes from the three different AHR
KD conditions (FDR < 0.1) identified 266 genes consistently deregulated in all conditions. (D) Confirmation of EPIC-DREM predictions. Cumulative
distribution of all expressed genes (black line), all EPIC-DREM predicted AHR target genes at the corresponding condition (blue line) and top 200 targets
of AHR (red line) in relation to their log2 FC upon AHR depletion per condition as indicated. The significance of the increased FC of the AHR targets was
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in all three conditions (Figure 7C). Enrichment analysis
for tissue-specific expression profiles of these genes in hu-
man and mouse gene atlas databases revealed smooth mus-
cle, adipocytes and osteoblasts as the most enriched cell
types, where the AHR regulated genes are normally ex-
pressed (Figure 7F). Consistently, inspection of publicly
available ChIP-seq data from various cell types revealed the
other regulators of the AHR targets to include CEBPB,
PPARG, andNR1H3, all of which are important regulators
involved in induction of genes during adipocyte differenti-
ation (77,78).
To further elucidate the role of AHR in the undiffer-
entiated cells and the potential impact on lineage-specific
genes, we asked how the deregulated genes were expressed in
normally differentiated day 15 adipocytes and osteoblasts.
The scatter plots in Figure 7G indicate the transcriptome
changes taking place upon AHR-KD in ST2 cells com-
pared to changes of the same genes in the differentiated cell
types. As indicated by the color coding, approximately half
of the genes affected by AHR-KD were also differentially
expressed after normal differentiation (286 in adipocytes
and 314 in osteoblasts). Moreover, genes that were upreg-
ulated in AHR-KD displayed preferential induction in the
differentiated cell types (Figure 7G, upper right quartile).
Therefore, AHR might serve as a guardian of the multipo-
tent state in the undifferentiated cells, with its downregu-
lation allowing increased expression of the lineage-specific
genes.
Taken together, the above findings support a role for
AHR as a regulator of lineage-specific genes that need to re-
main repressed in the multipotent bone marrow progenitor
cells. Among such genes induced upon AHR-KD we iden-
tified Notch3, a known regulator of cellular differentiation
(79) (Figure 7G andH). In both differentiation time courses
Notch3 expression showed an anti-correlated profile com-
pared toAhr, withNotch3 becoming induced whileAhr lev-
els decreased (Figure 5; Supplementary Figure S9D and E).
The Notch3 induction was also accompanied by increased
Notch4 levels in both lineages while the third abundantly
expressed receptor, Notch1, was concomitantly downregu-
lated (Supplementary Figure S9D and E). At last, to see
whether the impact of AHR on Notch3 is mediated via
GLIS1, we tested by RT-qPCR the effect of GLIS1-KD on
three of the Notch genes in the corresponding conditions
(Figure 7I). Interestingly, no effect could be seen onNotch3
expression uponGLIS1-KDwhile bothNotch1 andNotch2
were modestly affected. Thus, it appears that Notch signal-
ing could be a downstream target of AHRandGLIS1 in the
commitment of themesenchymal bonemarrow progenitors.
DISCUSSION
The ability to obtain unbiased GRNs and to identify their
key nodes for any given cell state transition in a data-driven
manner is becoming increasingly relevant for regenerative
and personalized medicine. Understanding such dynamic
networks can be improved by obtaining genome-wide time-
series datasets such as transcriptomics or epigenomics data.
To seamlessly integrate such datasets we have combined
time point-specific high accuracy TF binding predictions
with probabilistic modeling of temporal gene expression
data and applied it to our own time-series data from mes-
enchymal differentiation (Figures 2 and 3). Similar time se-
ries data collections have previously been used to study for
example hematopoiesis (7) and myeloid differentiation (6).
However, the derived dynamic GRNs have relied on experi-
mentally identified TF binding sites covering only a fraction
of all TF–target gene interactions, or on a sub-network of
selected TF–TF interactions, respectively.
EPIC-DREM can reveal the key TFs controlling co-
expressed gene sets of interest. Still, consistent with the co-
operative nature of TF activity (11), the number of puta-
tive master regulators is often very large. Recent work elu-
cidating the role of SEs in controlling cell type-specific mas-
ter regulators has provided researchers with a new tool for
data-driven identification of such regulators (9,10). We hy-
pothesized that merged SEs with dynamic behavior during
differentiation based on their H3K27ac signal would al-
low finding the genes, including the TFs, most relevant for
the dynamic process. Indeed, quantification of merged SEs
shows high correlation with expression levels of their puta-
tive target genes over time, both validating the approach and
allowing for more accurate association of SEs to their target
genes (Figure 4). A recent study applied a similar strategy
for SE quantification and further showed that SE dynamics,
as measured by MED1 occupancy, were predictive of en-
hancer looping to target genes, and highlighted H3K27ac
as the histone modification that best predicted such loop
dynamics, further supporting the validity of our approach
(80).
Combining EPIC-DREM results and dynamic SE pro-
filing points toward several TFs with potentially significant
roles in both lineages, including Foxn1, Ahr and Glis1 (Fig-
ure 4). In addition, dynamic SE profiling supports a role
for Hoxa10, although EPIC-DREM analysis did not place
it among the top TFs. Both Ahr and Glis1, and their SEs,
show an overall reduction in signal during both differen-
tiations, although with differential and lineage-specific dy-
namics (Figure 5 and Supplementary Figure S6), suggesting
that they could play an important role in maintaining mul-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
confirmed with the Kolmogorov–Smirnov test and the corresponding P-values are indicated. (E) Relative expression levels ofGlis1mRNA following AHR
KD in the three indicated conditions and followingAHRoverexpression in undifferentiated ST2 cells, and level ofAhr followingGLIS1 overexpression. See
panel 7A and panel 6F formore details onRT-qPCR analysis. (F) Enrichment analysis of the 266AHR targets identified in panel C for their preferred tissue
expression profiles in human and mouse, and proteins identified as shared regulators in existing ChIP-seq studies. Top five most enriched hits are shown
for each type of enrichment. X-axis indicates the combined enrichment score (43) and coloring the enrichment P-value. (G) Scatter plots indicating the
transcriptome-wide log2 FCs as measured by RNA-seq in undifferentiated ST2 cells with reduced AHR levels (x-axis) in comparison to the log2 FCs of the
same transcripts in D15 differentiated adipocytes (left panel) or osteoblasts (right panel). The color code separates transcripts expressed differentially only
in AHR-KD (yellow), or both in KD and in differentiation (red). (H) Notch3 is induced upon AHR downregulation in all tested conditions, as measured
by RNA-seq, while (I) Notch1 and Notch2 are affected by GLIS1 KD. See panel A for more details on RT-qPCR. See also Supplementary Figure S9 for
expression dynamics of Notch receptors during differentation.
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tipotent cells. On the contrary, the SE at the Foxn1 locus
shows a decrease in its signal in adipocyte differentiation
(data not shown), while in osteoblast differentiation the sig-
nal is further increased. Thus suggesting a role as a positive
driver of osteoblast differentiation, while potentially having
a negative role in adipocytes. Interestingly, FOXN1 has not
been previously shown to be involved in mesenchymal bone
marrow progenitor differentiation and our results warrant a
further investigation of FOXN1 function in adipocyte and
osteoblast differentiation.
Also GLIS1 has not been functionally associated to
adipocyte or osteoblast differentiation although recent
work has implicated it as differentially expressed in brown
adipocyte differentiation (81). However, consistent with a
potential role in the multipotent progenitors, GLIS1 has
been shown capable of promoting reprogramming of fibrob-
lasts to induced pluripotent stem cells (iPSCs) (61). Interest-
ingly, our analysis for enhancer signals at the GLIS1 locus
in different human cell types confirmed the presence of ac-
tive enhancers also in human mesenchymal stem cells but
not in embryonic stem cells (ESCs) (Supplementary Figure
S8). Thus, the ability of GLIS1 to promote cellular repro-
gramming of iPSCs might reflect its endogenous functions
inmultipotent stem cells likemesenchymal stem cells, rather
than the pluripotent ESCs. Our results implicate GLIS1 as
a regulator of multipotent ST2 cells with its reduction influ-
encing several lineage-specific genes and a failure to down-
regulate GLIS1 upon differentiation preventing normal lin-
eage commitment (Figures 6 and 7). In addition, both net-
work analysis and the expression dynamics suggest a role for
GLIS1 during adipogenesis (Figure 3A and Supplementary
Figure S6). Further work will be needed to elucidate the ex-
act role of GLIS1 in bone marrow and adipocyte differen-
tiation.
Unlike for GLIS1 and FOXN1, previous work has
already linked AHR separately to inhibition of both
adipocyte and osteoblast differentiation through studies on
biological impact of dioxin, an environmental toxin capa-
ble of activating AHR (71–73). In 3T3-L1 adipocytes this
inhibition is known to be mediated through overexpres-
sion of Ahr in a dioxin-independent manner (82), while in-
creased levels of Ahr expression in mesenchymal stem cells
in rheumatoid arthritis are inhibitory of osteogenesis (83).
Our results confirm the inhibitory effect of AHR over-
expression on differentiation of bone marrow adipocytes
while the effect of AHR expression alone on osteoblasto-
genesis remains unclear (Figure 6). This could be related to
the differential dynamics of Ahr in the two lineages, with
Ahr showing induction in early osteoblastogenesis prior to
its repression at later time points. Very recent work from
Watson et al. (84) demonstrated the inhibition of osteoblast
differentiation and the persistence of a multipotent state in
human bone marrow mesenchymal stem cells upon AHR
ligand activation. Future work will be needed to reveal
whether ligand availability and AHR transactivation status
influence its effects of osteoblastogenesis.
Nevertheless, the exact biological function of AHR in the
mesenchymal stem cells has remained unclear while main-
tenance of HSCs, located in the same niche of the bone
marrow, has been suggested to depend on the normal func-
tion of AHR (76). Moreover, as HSC maintenance also de-
pends on the cytokines and chemokines provided by the
mesenchymal stem cells, AHR is likely to impact HSCs
through its gene regulatory functions in both mesenchymal
stem cells and HSCs (16,85–86).
Here we show that repression ofAhr in mesenchymal dif-
ferentiation happens with lineage-specific dynamics and is
accompanied by similar reduction in signal of an exception-
ally large SE cluster downstream of Ahr. Together Ahr and
the SEs form their own TAD in mouse cells and in human
cells the SE signal is specific formesenchymal stem cells. An-
alyzing the contributions of the different constituents of the
Ahr-SEs will be important for understanding which path-
ways converge to regulate Ahr in mesenchymal stem cells
and whether they function in a synergistic manner as sug-
gested for some other large SEs (87,88).
A KD of AHR expression in the undifferentiated and
early stage differentiated cells already confirmed many of
the EPIC-DREM predictions and also revealed an enrich-
ment for lineage-specific genes among AHR targets, in-
cluding Notch3 (Figure 6). Notch signaling has been impli-
cated in numerous developmental processes with highly di-
verse outcomes (79) and also in ST2 cellsNotch3 regulation
is accompanied by changes in other Notch genes (Supple-
mentary Figure S9). Interestingly, AHR has been recently
linked to regulation of Notch signaling in mouse lymphoid
cells and testis (89,90). However, the affected Notch recep-
tors varied depending on the cell type in question. Notch
genes show different expression profiles across tissues and
cell types and Ahr-mediated regulation of Notch signaling
could be context-specific depending on the prevailing GRN
or chromatin landscape. Curiously, Notch3 has a cell type-
selective expression profile, favoring mesenchymal tissues
like bone, muscle and adipose tissue (91).
Our approach for identification of the dynamic GRNs
and SEs allows key regulator identification in various time
series experiments involving cell state changes. Our cur-
rent results together with previous data identify AHR and
GLIS1 as likely guardians of mesenchymal multipotency,
implicate additional TFs as novel regulators of adipocyte
and osteoblast differentiation, and provide an extensive re-
source for further analyses ofmesenchymal lineage commit-
ment.
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